Summit Global Investments’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,786
Closed -$230K 537
2023
Q2
$230K Buy
+1,786
New +$216K 0.02% 484
2021
Q2
Sell
-14,220
Closed -$1.28M 578
2021
Q1
$1.28M Buy
+14,220
New +$1.33M 0.08% 162

Other funds holding DXCM

Summit Global Investments's DXCM Position: Q3 2023 in Review

Summit Global Investments sold out of DexCom (DXCM) in Q3 2023, closing a stake of 1,786 shares — an estimated $230K sold.

Summit Global Investments first reported a position in DXCM in Q1 2021 and held it in 2 quarters. The position peaked at $1.28M in Q1 2021. 903 funds tracked by Wall St. Rank hold DXCM as of Q3 2023.

  • Summit Global Investments reported no remaining DexCom position as of Q3 2023 after selling out during the quarter.
  • Summit Global Investments sold 1,786 DexCom shares in Q3 2023, an estimated $230K.
  • Summit Global Investments first reported a position in DexCom in Q1 2021 and held it in 2 quarters.
  • Summit Global Investments's DexCom position peaked at $1.28M in Q1 2021.
  • 903 funds tracked by Wall St. Rank held DexCom as of Q3 2023.

Based on Summit Global Investments's 13F filing for Q3 2023, filed 16 Oct 2023.